Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Jun 10, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how eating eggs every day, particularly special nutrients-fortified eggs, can help improve eczema, a skin condition that causes itching and inflammation. The researchers believe that consuming eggs might lead to better skin health for people with eczema, and the fortified eggs may provide even more benefits. The study is currently recruiting participants aged 21 to 59 who have mild to moderate eczema and are generally healthy.
To join the study, participants need to be able to read and understand English and have a body mass index (BMI) between 18.5 and 25. They should not have any significant weight changes recently or be on certain medications, including dietary supplements that could affect the results. Participants will be asked to stop using any eczema medications during the study. Those who qualify will be closely monitored, and they can expect to provide feedback on their eczema condition throughout the trial. This study is a great opportunity for eligible individuals to explore how diet can influence skin health while contributing to valuable research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. English-literate and able to give informed consent in English
- • 2. Male and female participants, aged between 21 and 59 inclusive
- • 3. Healthy individuals with no underlying condition or on regular medication
- • 4. BMI between 18.5-25 kg/m2
- • 5. Mild to moderate severity of eczema, which will also be determined using our questionnaires during the screening visit
- Exclusion Criteria:
- • 1. Significant change in body weight (3 kg or more) in the past 3 months
- • 2. Significant exercise pattern over the past 3 months defined as high-intensity exercise of more than 3 hours per week
- • 3. Known food allergy to eggs
- • 4. Taking dietary supplements which may impact the study results
- • 5. Having gastrointestinal disorders not suitable for the study
- • 6. Current smokers
- • 7. Consumes more than 2 alcoholic drinks per day i.e. one drink is defined as either 150ml of wine, 340ml of beer/cider, or 45ml of distilled spirit
- • 8. Taking lipid-lowering and blood pressure-controlling medications for less than 3 years
- • 9. Pregnant or lactating women, or planning to conceive in the next 6 months
- • 10. Unwilling to stop the medication of eczema during the study, either topical creams or oral medications
- • 11. Hierarchical link (professional and familial ties) with the research team members
- • 12. Participating in another clinical study
- • 13. Having blindness in one eye or more, eye diseases, retinal/lens/optical nerve surgery, or other eye conditions that may impact the study results
- • 14. Low-quality macular pigment optical density results were determined during the screening visit.
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Jung Eun Kim, PhD, RD
Principal Investigator
National University of Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported